Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs
October 18, 2021
Tickers
ABEO
ABT
AVDL
AVRO
Tags
Penny Stocks
Benzinga
PSTV
From
Benzinga
3 COVID-19 Pill Stocks to Watch
October 16, 2021
Tickers
AVIR
MRK
PFE
RHHBY
Tags
RHHBY
PFE
AVIR
From
Motley Fool
Why Relay Therapeutics Is Up 30% This Week
October 15, 2021
Tickers
RHHBY
RLAY
Tags
RLAY
RHHBY
Market News
From
Motley Fool
2 Penny Stocks That Could Soar Soon
October 14, 2021
Tickers
AZN
BGNE
LPTX
PIRS
Tags
RHHBY
AZN
PIRS
From
Motley Fool
This Company Revolutionizes What Matters for Hospitals, Big Pharma and Health Insurers
October 14, 2021
Tickers
ABBV
BMY
GILD
JNJ
Tags
General
RHHBY
Healthcare Triangle
From
Benzinga
Is AstraZeneca Set to Soar With an Advanced Breast Cancer Treatment?
October 14, 2021
Tickers
AZN
RHHBY
Tags
RHHBY
AZN
Market News
From
Motley Fool
The Daily Biotech Pulse: Moderna Awaits Adcom Ruling On COVID-19 Booster Shot; Teligent Files For Chapter 11; CFO Transitions at Catalyst Biosciences, CRISPR; Lucid Diagnostics Debuts
October 14, 2021
Tickers
CBIO
CRSP
FBIO
IPOS
Tags
TPTX
Guidance
PAVM
From
Benzinga
Never Mind Ginkgo Bioworks' Drama -- This Synthetic Biology Stock Is Still a Buy
October 13, 2021
Tickers
AMRS
DNA
RHHBY
TGT
Tags
DNA
Market News
AMRS
From
Motley Fool
3 COVID Stocks That Can Turn $1,000 Into $10,000
October 12, 2021
Tickers
AVIR
DOCS
FB
ILMN
Tags
MRNA
FB
DOCS
From
Motley Fool
Sarepta's Duchenne Gene Therapy Shows Sustained Functional Improvements
October 11, 2021
Tickers
RHHBY
SRPT
Tags
Market News
Trading Ideas
Benzinga
From
Benzinga
4 Key Things Investors Should Know About Pfizer's Experimental COVID-19 Pill
October 11, 2021
Tickers
AVIR
MRK
PFE
RHHBY
Tags
PFE
RHHBY
AVIR
From
Motley Fool
Roche's Alzheimer's Candidate Secures FDA Breakthrough Designation
October 08, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
Movers
Briefs
News
From
Benzinga
Can This Duo Outperform Merck and Ridgeback Biotherapeutics' COVID Treatment?
October 08, 2021
Tickers
AVIR
MRK
MRNA
NVAX
Tags
RHHBY
MRNA
PFE
From
Motley Fool
Merck's Oral COVID-19 Treatment Could Be Game-Changer: BofA Analyst
October 06, 2021
Tickers
BNTX
JNJ
MRK
MRNA
Tags
General
RHHBY
Price Target
From
Benzinga
Why Novavax Stock Plunged in September
October 06, 2021
Tickers
AVIR
BNTX
MRNA
NVAX
Tags
Market News
AVIR
NVAX
From
Motley Fool
Moderna Is Down 12%. Is It Time to Buy?
October 06, 2021
Tickers
MRK
MRNA
RHHBY
Tags
Market News
MRK
MRNA
From
Motley Fool
Which COVID-19 Pill Stock Is the Best Buy?
October 05, 2021
Tickers
AVIR
BNTX
MRK
PFE
Tags
AVIR
MRK
Market News
From
Motley Fool
2 Best Biotech Stocks to Buy In October
October 04, 2021
Tickers
AVIR
IBB
MRK
OCGN
Tags
AVIR
IBB
Market News
From
Motley Fool
3 Stocks That Might Soar With Pills for COVID
October 03, 2021
Tickers
AVIR
MRK
MRNA
NVAX
Tags
REGN
RHHBY
MRNA
From
Motley Fool
Here Are the Leaders in the Race to Develop a COVID-19 Pill
October 03, 2021
Tickers
AVIR
MRK
PFE
RDHL
Tags
PFE
MRK
Market News
From
Motley Fool
Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates
October 01, 2021
Tickers
ANIP
AVDL
BHC
CALT
Tags
MRK
SGEN
GILD
From
Benzinga
Labcorp's At Home Collection Kit Gets EUA Nod For Combined COVID-19 and Flu Detection
October 01, 2021
Tickers
LH
RHHBF
RHHBY
RHHVF
Tags
Health Care Services
Health Care
Benzinga
From
Benzinga
BioNTech Starts Dosing In Mid-Stage Colorectal Cancer Immunotherapy Trial
October 01, 2021
Tickers
BNTX
RHHBF
RHHBY
RHHVF
Tags
RHHVF
RHHBF
Movers
From
Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
Tickers
ABBV
ADMA
AGTC
AIM
Tags
FBRX
EBS
AGTC
From
Benzinga
Regeneron-Roche Post Encouraging New Data For COVID-19 Antibody Cocktail
September 30, 2021
Tickers
REGN
RHHBF
RHHBY
RHHVF
Tags
Phase 2 Trial
Market News
Benzinga
From
Benzinga
3 COVID Stocks Ready to Take On the Delta Variant
September 27, 2021
Tickers
BNTX
GILD
LLY
NVAX
Tags
RHHBY
BNTX
PFE
From
Motley Fool
Glaxo - Vir Biotech's COVID Treatment Approved In Japan
September 27, 2021
Tickers
GSK
REGN
RHHBF
RHHBY
Tags
FDA
Benzinga
Market News
From
Benzinga
3 Biotech Stocks That Could Make You Filthy Rich
September 27, 2021
Tickers
ADAP
AMGN
AZN
CHGCY
Tags
ADAP
RHHBY
NVAX
From
Motley Fool
Acceleron In Advanced $11B Buyout Talks: Bloomberg
September 27, 2021
Tickers
AMGN
BMY
GILD
MRK
Tags
Market News
GILD
MRK
From
Benzinga
September Sell-Off Alert: Buy Vertex Pharmaceuticals on the Dip
September 25, 2021
Tickers
CRSP
NDAQ
RHHBY
VRTX
Tags
NDAQ
Market News
RHHBY
From
Motley Fool
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.